[5-(2-cyclopropyloxy-5-fluoro-3-methoxyphenyl)-1-methylpyrrolidin-3-yl]methanamine
C16H23FN2O2 — CID 117474992
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-(2-cyclopropyloxy-5-fluoro-3-methoxyphenyl)-1-methylpyrrolidin-3-yl]methanamine
[5-(2-cyclopropyloxy-5-fluoro-3-methoxyphenyl)-1-methylpyrrolidin-3-yl]methanamine (PubChem CID 117474992) has the molecular formula C16H23FN2O2 and a molecular weight of 294.37 g/mol. Its IUPAC name is [5-(2-cyclopropyloxy-5-fluoro-3-methoxyphenyl)-1-methylpyrrolidin-3-yl]methanamine.
Molecular Properties
| Compound Name | [5-(2-cyclopropyloxy-5-fluoro-3-methoxyphenyl)-1-methylpyrrolidin-3-yl]methanamine |
|---|---|
| PubChem CID | 117474992 |
| Molecular Formula | C16H23FN2O2 |
| Molecular Weight | 294.37 g/mol |
| Exact Mass | 294.17 |
| IUPAC Name | [5-(2-cyclopropyloxy-5-fluoro-3-methoxyphenyl)-1-methylpyrrolidin-3-yl]methanamine |
| SMILES | COc1cc(F)cc(C2CC(CN)CN2C)c1OC1CC1 |
| InChI | InChI=1S/C16H23FN2O2/c1-19-9-10(8-18)5-14(19)13-6-11(17)7-15(20-2)16(13)21-12-3-4-12/h6-7,10,12,14H,3-5,8-9,18H2,1-2H3 |
| InChIKey | ZMFWGHGBQFIWEC-UHFFFAOYSA-N |
| XLogP | 2.33 |
| TPSA | 47.72 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 294.37 |
| LogP ≤ 5 | 2.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117474992 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.